Press Release Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 2 hours ago
Press Release Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients Aug 13